ClearSky MD is a brand specializing in the development of innovative technologies for the diagnosis and monitoring of neurodegenerative conditions such as Parkinson’s and Alzheimer’s. Their clinically-validated medical devices have been used in medical centers and clinical trials worldwide. Led by Professor Stephen Smith, a renowned expert in Parkinson’s research, ClearSky MD collaborates with specialists from Leeds General Infirmary, Heriot-Watt University, and the University of York to combine clinical expertise with machine learning knowledge.

ClearSky MD offers a range of cutting-edge products to aid in the diagnosis and monitoring of neurodegenerative conditions. Their product lineup includes the LID-Monitor, which enables safe monitoring of dyskinesia side effects of Parkinson’s medication at home. The ND-Monitor utilizes data gloves with positioning sensors to differentiate between different neurodegenerative conditions.

PD-Monitor assists specialists in confirming Parkinson’s disease diagnosis by measuring symptoms during routine tasks. Lastly, the CF-Monitor objectively assesses visuo-spatial ability using evolutionary algorithms. In addition to their innovative products, ClearSky MD is involved in clinical studies and has been recognized as a UK Life Sciences Innovator for 2023.

They also participate in international events and conferences to further their mission of advancing digital healthcare. To learn more or schedule a demonstration, interested parties can contact ClearSky MD through their website